Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-19-017194
Filing Date
2019-04-01
Accepted
2019-04-01 06:30:36
Documents
5
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tv517651_10ka.htm 10-K/A 140668
2 EXHIBIT 31.3 tv517651_ex31-3.htm EX-31.3 7060
3 EXHIBIT 31.4 tv517651_ex31-4.htm EX-31.4 7039
4 EXHIBIT 32.3 tv517651_ex32-3.htm EX-32.3 3956
5 EXHIBIT 32.4 tv517651_ex32-4.htm EX-32.4 3646
  Complete submission text file 0001144204-19-017194.txt   163598
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34058 | Film No.: 19718717
SIC: 2834 Pharmaceutical Preparations